Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Foster

Showing results (1271-1280 of 1,472) with videos related to

Pageof 148
Sort By:
Blood Advances|April 12, 2021
Transfer to the clinic: refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactorsAmanda L Evans, Amanda Dalby, Holly R Foster, et al.
Journal of Thrombosis and Haemostasis : JTH|March 16, 2025
Corticosteroid use to mitigate transaminitis-associated decline in FVIII levels following valoctocogene roxaparvovec gene therapy: clinical practice guidanceBarbara A Konkle, Flora Peyvandi, Graham R Foster, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2017
Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosisTarik Asselah, Stefan Bourgeois, Stephen Pianko, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 22, 2019
Stimulation of Caveolin-1 Signaling Improves Arteriovenous Fistula PatencyTakuya Hashimoto, Toshihiko Isaji, Haidi Hu, et al.
Journal of Hepatology|July 6, 2015
Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis BHenry Lik-Yuen Chan, Magdy Elkhashab, Huy Trinh, et al.
Drug and Alcohol Dependence|December 12, 2018
Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use: An integrated analysis of 7 phase III studiesGraham R Foster, Gregory J Dore, Stanley Wang, et al.
Journal of Hepatology|July 9, 2016
Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosisMichelle C M Cheung, Alex J Walker, Benjamin E Hudson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 2, 2008
Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B)Aminah Jatoi, Shaker R Dakhil, Nathan R Foster, et al.
Toxicologic Pathology|June 23, 2012
Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes--conclusions from the 3rd International ESTP Expert WorkshopA P Hall, C R Elcombe, J R Foster, et al.
Journal of Hepatology|December 3, 2014
Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infectionKosh Agarwal, Scott K Fung, Tuan T Nguyen, et al.
Pageof 148

Showing results (1271-1280 of 1,472) with videos related to

Sort By:
Pageof 148
Blood Advances|April 12, 2021
Transfer to the clinic: refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactorsAmanda L Evans, Amanda Dalby, Holly R Foster, et al.
Journal of Thrombosis and Haemostasis : JTH|March 16, 2025
Corticosteroid use to mitigate transaminitis-associated decline in FVIII levels following valoctocogene roxaparvovec gene therapy: clinical practice guidanceBarbara A Konkle, Flora Peyvandi, Graham R Foster, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2017
Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosisTarik Asselah, Stefan Bourgeois, Stephen Pianko, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 22, 2019
Stimulation of Caveolin-1 Signaling Improves Arteriovenous Fistula PatencyTakuya Hashimoto, Toshihiko Isaji, Haidi Hu, et al.
Journal of Hepatology|July 6, 2015
Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis BHenry Lik-Yuen Chan, Magdy Elkhashab, Huy Trinh, et al.
Drug and Alcohol Dependence|December 12, 2018
Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use: An integrated analysis of 7 phase III studiesGraham R Foster, Gregory J Dore, Stanley Wang, et al.
Journal of Hepatology|July 9, 2016
Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosisMichelle C M Cheung, Alex J Walker, Benjamin E Hudson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 2, 2008
Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B)Aminah Jatoi, Shaker R Dakhil, Nathan R Foster, et al.
Toxicologic Pathology|June 23, 2012
Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes--conclusions from the 3rd International ESTP Expert WorkshopA P Hall, C R Elcombe, J R Foster, et al.
Journal of Hepatology|December 3, 2014
Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infectionKosh Agarwal, Scott K Fung, Tuan T Nguyen, et al.
Pageof 148